Abstract
We have coined the term “Malignant Obesity Hypoventilation Syndrome” (MOHS) to describe a severe multisystem disease due to the systemic effects of obesity. Patients with this syndrome have severe obesity related hypoventilation together with systemic hypertension, diabetes and the metabolic syndrome, left ventricular hypertrophy with diastolic dysfunction, pulmonary hypertension and hepatic dysfunction. Patients with MOHS are frequently admitted to the ICU with hypercapnic respiratory failure and have a high mortality. This syndrome is largely unrecognized as physicians do not make the association between the patients’ multiple medical problems and obesity. Due to the delayed diagnosis and progressive morbidities of this condition all patients with a BMI > 40 kg/m2 should be screened for MOHS. The management of patients with MOHS includes short term measures to improve the patients’ medical condition and long term measures to achieve enduring weight loss. Bariatric surgery reverses or improves the multiple metabolic and organ dysfunctions associated with MOHS and should be strongly considered in these patients.
Keywords: Diabetes, diastolic heart failure, metabolic syndrome, myocardial hypotrophy, non-acholic steato-hepatitis, obesity, obesity hypoventilation syndrome, pulmonary hypertension.
Current Respiratory Medicine Reviews
Title:The Malignant Obesity Hypoventilation Syndrome (MOHS)
Volume: 10 Issue: 4
Author(s): Paul E. Marik and Joseph Varon
Affiliation:
Keywords: Diabetes, diastolic heart failure, metabolic syndrome, myocardial hypotrophy, non-acholic steato-hepatitis, obesity, obesity hypoventilation syndrome, pulmonary hypertension.
Abstract: We have coined the term “Malignant Obesity Hypoventilation Syndrome” (MOHS) to describe a severe multisystem disease due to the systemic effects of obesity. Patients with this syndrome have severe obesity related hypoventilation together with systemic hypertension, diabetes and the metabolic syndrome, left ventricular hypertrophy with diastolic dysfunction, pulmonary hypertension and hepatic dysfunction. Patients with MOHS are frequently admitted to the ICU with hypercapnic respiratory failure and have a high mortality. This syndrome is largely unrecognized as physicians do not make the association between the patients’ multiple medical problems and obesity. Due to the delayed diagnosis and progressive morbidities of this condition all patients with a BMI > 40 kg/m2 should be screened for MOHS. The management of patients with MOHS includes short term measures to improve the patients’ medical condition and long term measures to achieve enduring weight loss. Bariatric surgery reverses or improves the multiple metabolic and organ dysfunctions associated with MOHS and should be strongly considered in these patients.
Export Options
About this article
Cite this article as:
E. Marik Paul and Varon Joseph, The Malignant Obesity Hypoventilation Syndrome (MOHS), Current Respiratory Medicine Reviews 2014; 10 (4) . https://dx.doi.org/10.2174/1573398X11666150427223059
DOI https://dx.doi.org/10.2174/1573398X11666150427223059 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biological Activities of Receptor-interacting Protein 140 in Adipocytes and Metabolic Diseases
Current Diabetes Reviews Mechanical Circulatory Support of the Critically Ill Child Awaiting Heart Transplantation
Current Cardiology Reviews MicroRNA 21 Emerging Role in Diabetic Complications: A Critical Update
Current Diabetes Reviews Generation of Human Cardiomyocytes for Cardiac Regenerative Therapies: Differentiation and Direct Reprogramming
Current Pharmaceutical Design S-nitrosation/Denitrosation in Cardiovascular Pathologies: Facts and Concepts for the Rational Design of S-nitrosothiols
Current Pharmaceutical Design Blockade of Renin Angiotensin System Ameliorates the Cardiac Arrhythmias and Sympathetic Neural Remodeling in Hearts of Type 2 DM Rat Model
Endocrine, Metabolic & Immune Disorders - Drug Targets Modular Nanotransporters for Targeted Intracellular Delivery of Drugs: Folate Receptors as Potential Targets
Current Pharmaceutical Design Methods for Identifying Cardiovascular Agents: A Review
Recent Patents on Cardiovascular Drug Discovery Application of Mitochondria-Targeted Pharmaceuticals for the Treatment of Heart Disease
Current Pharmaceutical Design Decreased Vascular Repair and Neovascularization with Ageing: Mechanisms and Clinical Relevance with an Emphasis on Hypoxia- Inducible Factor-1
Current Molecular Medicine Occurrence and Clinical Impact of Microembolic Signals (MES) in Patients with Chronic Cardiac Diseases and Atheroaortic Plaques - A Systematic Review
Current Vascular Pharmacology Bioenergetics and Mitochondrial Dysfunction in Aging: Recent Insights for a Therapeutical Approach
Current Pharmaceutical Design Orthotopic Liver Transplantation in Alcoholic Liver Disease Patients
Reviews on Recent Clinical Trials The Role of Molecular Imaging in the Assessment of Cardiac Amyloidosis: State-of-the-Art
Current Radiopharmaceuticals Pure Polyphenols Applications for Cardiac Health and Disease
Current Pharmaceutical Design Coated with Nanomaterials Intraocular Lenses, Ophthalmic and Human Body Implantable Devices with High Catalytic Antioxidant Activities: A New Nanotechnology Strategy of Peroxidase Cellular Enzyme Mimics Increasing the Biocompatibility and Therapeutic Deployment of the Medical Prosthetic Device
Recent Patents on Drug Delivery & Formulation Pharmacological Approaches in the Treatment of Atrial Fibrillation
Current Medicinal Chemistry Prevalence of Major Cardiac Events of Anthracycline-Induced Cardiotoxicity in Southwestern Iran: Different Response Patterns to Cumulative Dose
Current Drug Therapy Efficacy of Enzyme Replacement Therapy in Fabry Disease
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Secretory Leukocyte Protease Inhibitor: More than Just A Protease Inhibitor
Current Immunology Reviews (Discontinued)